Is this you? Create Your Porfile
Avatar

Klaus Ehrlich

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Klaus Ehrlich is active.

Explore More

Publication

Featured researches published by Klaus Ehrlich.

The Journal of Antibiotics | 2002

Cyclipostins, Novel Hormone-sensitive Lipase Inhibitors from Streptomyces sp. DSM 13381 II. Isolation, Structure Elucidation and Biological Properties

Laszlo Vertesy; Bernd Beck; Mark Brönstrup; Klaus Ehrlich; Michael Kurz; Günter Müller; Dietmar Schummer; Gerhard Seibert

The Journal of Antibiotics | 2001

Pluraflavins, Potent Antitumor Antibiotics from Saccharothrix sp. DSM 12931.

Laszlo Vertesy; Francis P. Barbone; Elizabeth Cashmen; Heinrich Decker; Klaus Ehrlich; Birgit Jordan; Martin Knauf; Dietmar Schummer; Marian Paul Segeth; Joachim Wink; Gerhard Seibert

Archive | 2002

Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Marian Paul Segeth; Luigi Toti

Archive | 2001

Cyclipostins, process for their preparation and use thereof

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Joachim Wink

Archive | 2003

CYCLIPOSTINS, A METHOD FOR THEIR PRODUCTION AND THE USE OF THE SAME

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Joachim Wink

Archive | 2001

Pluraflavins and derivatives thereof, process for their preparation and use thereof

Laszlo Vertesy; Klaus Ehrlich; Martin Knauf; Joachim Wink; Francis P. Barbone; Elaine A. Powers; Elizabeth A. Cashman

Archive | 2009

Coniosetine, process for preparation and use as medicament

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Marian Paul Segeth; Luigi Toti

Archive | 2002

Coniosetin, process for its preparation and use as medicaments

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Marian Paul Segeth; Luigi Toti

Archive | 2002

Coniosulfides and derivatives thereof, processes for their preparation and use as medicaments

Laszlo Vertesy; Klaus Ehrlich; Michael Kurz; Marian Paul Segeth; Luigi Toti

Archive | 2001

Pluraflavins and its derivatives, process for their preparation and use thereof.

Francis P. Barbone; Elizabeth A. Cashman; Klaus Ehrlich; Martin Knauf; Elaine A. Powers; Laszlo Vertesy; Joachim Wink

Explore More

Collaboration

Dive into the Klaus Ehrlich's collaboration.

Top Co-Authors
Avatar

Laszlo Vertesy

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Martin Knauf

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Francis P. Barbone

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Marian Paul Segeth

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Michael Kurz

Illinois State University

View shared research outputs
Top Co-Authors
Avatar

Elaine A. Powers

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Elizabeth A. Cashman

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Luigi Toti

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Joachim Wink

Hoechst Schering AgrEvo GmbH

View shared research outputs
Top Co-Authors
Avatar

Michael Kurz

Illinois State University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge